The 2009-2014 World Outlook for Optical Goods and Eye Care Products

Icon Group International, Inc.
September 27, 2008
186 Pages - SKU: ICON1960508
License type:
Countries covered: Global

This econometric study covers the world outlook for optical goods and eye care products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level.

The study also does not consider short-term cyclicalities that might affect realized sales.

The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the 230 countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for optical goods and eye care products. It also shows how the P.I.E. is divided across the world’s regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.



Additional Information

This econometric study covers the world outlook for optical goods and eye care products across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved.

More Global Ophthalmology Reports

Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012 by GlobalData
Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Keratoconjunctivitis sicca (Dry Eye) Global Clinical Trials Review, H1, 2012 provides data ...

Cataract Global Clinical Trials Review, H1, 2012 by GlobalData
Cataract Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Cataract Global Clinical Trials Review, H1, 2012 provides data on the Cataract clinical trial scenario. ...

3rd World Congress on Controversies in Ophthalmology 2012 - Post-Conference Review and Analysis by GlobalData
3rd World Congress on Controversies in Ophthalmology 2012 - Post-Conference Review and Analysis Summary GlobalData, the industry analysis specialist, has released its new conference alerts, “3rd World ...

Diarrhea Global Clinical Trials Review, H1, 2012 by GlobalData
Diarrhea Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2012 provides data on the Diarrhea clinical trial scenario. ...

Ophthalmic Drugs: World Market Prospects 2012-2022 by Visiongain
How to find trends and revenue predictions for the ophthalmic drug industry What are the commercial prospects for treating eye disorders? Visiongain's report shows you ...

See all reports like this >>